KTU Ultrasound Breakthrough Blood Flow
Analysis based on 6 articles · First reported May 18, 2026 · Last updated May 26, 2026
The discovery by Kaunas University of Technology could lead to new non-invasive therapies for cardiovascular diseases, Alzheimer s disease, and Diabetes, potentially reducing reliance on existing medication and surgical procedures. This could create new market opportunities for medical device companies specializing in ultrasound technology and impact pharmaceutical companies by offering alternative treatment modalities.
Researchers at Kaunas University of Technology, led by Vytautas Ostaševičius, have made a significant breakthrough in understanding how ultrasound influences blood flow. Their study, published in Sensors (journal), reveals that low-frequency ultrasound can separate red blood cell clusters, decreasing blood viscosity and improving oxygen exchange. This contrasts with high-frequency ultrasound, which promotes aggregation. The research, inspired by the COVID-19 pandemic, involved developing a patented low-frequency ultrasound transducer capable of penetrating tissues four times deeper than conventional devices. This technology holds potential for non-invasive treatments in various medical fields, including improving oxygen delivery in Cancer therapy, temporarily opening the blood-brain barrier for drug delivery in Alzheimer s disease, and enhancing circulation for diabetic foot ulcers in Diabetes. The findings suggest a shift in ultrasound's role from purely diagnostic to an active therapeutic agent, potentially complementing or replacing existing treatments.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard